Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Lactulose Fresenius 670mg/ml Oral Solution - PA0773/003/001
- Rowalief 500mg Film-coated tablets - PA0074/065/001
- Sevredol 20mg Film-coated Tablets - PA1688/009/002
- Somavert 20mg powder and solvent for solution for injection - EU/1/02/240/003
- Vancomycin Mylan 500mg, powder for solution for infusion - PA0577/163/001
The following shortages have been resolved and supply has resumed to the Irish market:
- Canesten HC 1% w/w & 1% w/w Cream - PA1410/040/002
- Caverject 20 micrograms Powder and Solvent for Solution for Injection - PA0822/115/003
- Epaclob 1mg/ml Oral Suspension - PA0549/026/001
- Epaclob 2mg/ml Oral Suspension - PA0549/026/002
- Gaviscon Advance Oral Suspension - PA0979/011/001
- Palexia 4mg/ml oral solution - PA2242/012/010
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.